Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 crossover trial of subcutaneous recombinant human erythropoietin biosimilar in healthy adult men
RBR-78vysgPhase 1Not yet recruiting
- Sponsor
- Laboratório Daudt
- Start
- Feb 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised trial of erythropoietin in anaemia (2 arms), sponsored by Laboratório Daudt. Planned start Feb 2020; status: not yet recruiting.
02
Drugs
erythropoietin
03
Conditions
anaemia
Beyond the preview
Go deeper on RBR-78vysg.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-78vysg.